- Home
- NN vs BCRX Comparison
NN vs BCRX Comparison
Compare NN & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NN
- BCRX
- Stock Information
- Founded
- NN 2007
- BCRX 1986
- Country
- NN United States
- BCRX United States
- Employees
- NN N/A
- BCRX N/A
- Industry
- NN Industrial Machinery/Components
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NN Industrials
- BCRX Health Care
- Exchange
- NN Nasdaq
- BCRX Nasdaq
- Market Cap
- NN 1.5B
- BCRX 1.7B
- IPO Year
- NN N/A
- BCRX 1994
- Fundamental
- Price
- NN $13.93
- BCRX $9.92
- Analyst Decision
- NN
- BCRX Buy
- Analyst Count
- NN 0
- BCRX 8
- Target Price
- NN N/A
- BCRX $16.75
- AVG Volume (30 Days)
- NN 900.5K
- BCRX 5.7M
- Earning Date
- NN 05-09-2025
- BCRX 05-05-2025
- Dividend Yield
- NN N/A
- BCRX N/A
- EPS Growth
- NN N/A
- BCRX N/A
- EPS
- NN N/A
- BCRX N/A
- Revenue
- NN $5,669,000.00
- BCRX $503,485,000.00
- Revenue This Year
- NN $42.99
- BCRX $27.64
- Revenue Next Year
- NN $122.93
- BCRX $13.42
- P/E Ratio
- NN N/A
- BCRX N/A
- Revenue Growth
- NN 46.79
- BCRX 41.67
- 52 Week Low
- NN $6.47
- BCRX $5.06
- 52 Week High
- NN $18.54
- BCRX $11.11
- Technical
- Relative Strength Index (RSI)
- NN 65.60
- BCRX 65.51
- Support Level
- NN $12.44
- BCRX $8.28
- Resistance Level
- NN $13.60
- BCRX $11.11
- Average True Range (ATR)
- NN 0.70
- BCRX 0.51
- MACD
- NN 0.21
- BCRX 0.25
- Stochastic Oscillator
- NN 92.38
- BCRX 69.17
About NN NextNav Inc.
NextNav Inc provides GPS service. The company NextNav TerraPoiNT system keeps critical infrastructure resilient with reliable Position, Navigation, and Timing services in the absence of GPS.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.